Vanguard Group Inc Delcath Systems, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
79Shares Held
7.02MCall Options Held
198KPut Options Held
41.7K-
Aigh Capital Management LLC Baltimore, MD1.39MShares$22.2 Million6.61% of portfolio
-
Vivo Capital, LLC Palo Alto, CA997KShares$16 Million1.32% of portfolio
-
Geode Capital Management, LLC Boston, MA289KShares$4.62 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny205KShares$3.28 Million0.0% of portfolio
-
Polar Asset Management Partners Inc. Toronto, A6177KShares$2.82 Million0.05% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $138M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...